Challenge & Opportunity
Poor-quality medicines threaten families, countries and global health progress everywhere, and yet they are rarely prioritized – or even discussed –by political leaders, health advocates, researchers or journalists. Those people who have committed to work on safe, quality medicines often lack platforms to coordinate their advocacy for maximum impact.
This is where we come in. A campaign on the right to safe, quality medicines can:
- Generate a sense of urgency by raising awareness of the scope and impact of the problem
- Put people and their experiences first to illustrate that poor-quality medicines cannot be confined to technical, isolated conversations; they are a fundamental breach of patient trust with life-or-death consequences
- Inspire collective action and unify a diverse and broad coalition of partners
The World Health Organization’s recently-launched landmark report on poor-quality medicines has given us new evidence, visibility and momentum to bring this issue to more people than ever before.
We also can't afford to wait any longer. This is a problem that puts millions of lives at risk, costs economies billions, accelerates antimicrobial resistance and undermines trust in health systems. The time to act is now.
Watch Video Recap of Campaign Announcement
On 23 May 2018, on the sidelines of the 71st World Health Assembly in Geneva, USP and partners announced a new campaign on the right to safe, quality medicines at an event entitled "Medicines We Can Trust: A Call to Safeguard Quality." Watch the recap here.